CZC-25146
CZC-25146 is a potent and orally active LRRK2 inhibitor with IC50 values of 4.76 nM and 6.87 nM for wild-type LRRK2 and G2019S LRRK2, respectively. CZC-25146 inhibits PLK4, GAK, TNK1, CAMKK2 and PIP4K2C as well. CZC-25146 prevents mutant LRRK2-induced injury of neurons in vitro. CZC-25146 exhibits relatively favorable pharmacokinetic properties in mice. CZC-25146 can increase normal α-1-antitrypsin (AAT) secretion and reduce inflammatory cytokines. CZC-25146 can be used to research Parkinson's disease and liver diseases[1][2][3].
Product Specifications
CAS Number
[1191911-26-8]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
LRRK2; TNK1
Type
Reference compound
Related Pathways
Autophagy; Protein Tyrosine Kinase/RTK
Applications
Neuroscience-Neuromodulation
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/CZC-25146.html
Concentration
10mM
Purity
99.10
Solubility
DMSO : ≥ 46 mg/mL
Smiles
CS(=O)(NC1=CC=CC=C1NC2=NC(NC3=CC=C(N4CCOCC4)C=C3OC)=NC=C2F)=O
Molecular Formula
C22H25FN6O4S
Molecular Weight
488.54
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GPR65, CT (GPR65, TDAG8, Psychosine receptor, G-protein coupled receptor 65, T-cell death-associated gene 8 protein) (MaxLight 490)
GPR65, CT (GPR65, TDAG8, Psychosine receptor, G-protein coupled receptor 65, T-cell death-associated gene 8 protein) (MaxLight 490)
